Interview: Hoori Kaskanian, Pfizer Global Established Products BU Head…
Pfizer Global Established Products’ BU Head and Hospira’s Director of Institutional Affairs tell us about…
Address: #11-06 Parkview Square 600 North Bridge Rd Singapore 188778 ,Singapore
Tel: + 65 6299 6880
Hospira is the world’s leading provider of injectable drugs and infusion technologies, backed by proven leadership and more than 70 years’ experience producing high-quality products. Hospira’s breadth of offerings help customers address the safety, productivity and cost of patient care. Used by hospitals worldwide, Hospira products are also prevalent in outpatient clinics and other alternate healthcare sites.
injectable drugs and medical devices
Pfizer Global Established Products’ BU Head and Hospira’s Director of Institutional Affairs tell us about…
Carolina López-Torres joined Hospira Peru in 2011 following a dynamic career at Novartis. She discusses the early…
In 2010, you began your last interview with us by mentioning two things: that because of the nature of this…
Prior to Hospira, you worked for a number of years in several positions at Bayer. What opportunities did you see in…
Hospira Mexico is not only the control centre for Central America and Caribbean operations, but it is the Latin…
What is exciting about the Taiwanese market for Hospira today? Hospira is a US-based company, which used to be…
The Chilean operations for Hospira also manage the Argentine and Uruguayan operations of the company. What led to…
Hospira, which was spun-off from Abbott Laboratories in 2004, is a global specialty pharmaceutical and medication…
Leonora Lim, DHL’s Asia-Pacific VP for Life Sciences and Healthcare, Customer Solutions & Innovation, dives…
Siemens Healthineers Singapore’s Ai Li Siow outlines how her affiliate has pivoted in order to continue to…
Changi Airport Group’s Ching Kiat LIM reflects on a challenging 2020 for the airline industry, Changi’s…
Andrew Frye of medtech giant Baxter outlines his management strategy for the diverse APAC region, how growth was…
Singapore – despite its modest USD 1.22 billion domestic market – has long been one of Asia’s leading…
Singapore’s Institute of Mental Health offers a comprehensive range of psychiatric, rehabilitative, and…
Kevin Zou highlights Novartis Oncology’s footprint and priorities in the diverse Asia-Pacific region, the…
Medtech industry veteran Sanjay Prabhakaran outlines the footprint and strategy of women’s health specialist…
Novo Nordisk Singapore’s Praful Chakkarwar explains how he leverages his experience in a range of geographies…
Nawal Roy of global digital health platform Holmusk which aims to establish data as a core utility to the treatment…
ASLAN Pharmaceuticals is a clinical-stage immunology-focused biopharmaceutical company. CEO Dr Carl Firth reveals…
As the most important pharma hub in its region, and one of the most important globally, many companies look to…